> News > Vanarix raised CHF 4 Million to begin new clinical trials
10.07
2024

Vanarix raised CHF 4 Million to begin new clinical trials

Founded in 2018, Vanarix is a clinical stage startup specialising in regenerative medicine, focusing on articular cartilage regeneration. Despite being a small team of three people, the startup has already achieved incredible millstones, from successful clinical trials to raising CHF 4 Million, in their journey to improve patients’ lives.

Company related to the news